The Centenary Institute has held its inaugural ‘Inflammation Symposium’ on 13 and 14 July, highlighting the latest in medical research across the field of inflammation and disease.
Bringing together Centenary researchers, as well as world-leading inflammation researchers from across Australia and overseas, the aim was to feature the strength of Centenary’s inflammation research, to promote discussion and to extend collaboration opportunities to maximise research outcomes.
Professor Phil Hansbro (pictured), Director of the Centenary UTS Centre for Inflammation and symposium convener, was pleased at how successful and informative the two-day symposium was.
“We were delighted to have presentations from experts from high profile inflammation centres located within the University of Queensland; the Hudson and Garvan Institutes of Medical Research and the University of Manchester (UK).”
“The symposium provided an ideal platform to define capabilities and to explore ways to potentially extend research activity and collaborations between institutions. Enabling collaborations can benefit investigator studies and can also aid in developing new funding opportunities,” said Professor Hansbro.
Presentations at the symposium included current studies on lung and mucosal immunity, liver inflammation, the aged vasculature and the role of the gut-lung axis in chronic obstructive pulmonary disease (COPD).
Dr Orchard discusses sudden cardiac death in athletes–how to screen for it, prepare for it, treat it and, ultimately, hopefully prevent it.
Professor Chris Semsarian AM gives his response to recent studies linking Pfizer’s COVID-19 vaccine with myocarditis.
Researchers from the Centenary Institute and the Royal Prince Alfred Hospital are co-investigators on three newly funded liver cancer projects.